Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 268
Growth YoY: +12.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,897)

clinicaltrialsPublishedShowing 901–950 of 2,282 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02192671	HR Versus RFA for HCC in Patients With PHT(HR-HCC/PHT)	unknown	Phase 3	120	Guangxi Medical UniversityOTHER	1	Jan 18, 2022	clinicaltrials
NCT03988998	Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma	unknown	Phase 3	100	Guangxi Medical UniversityOTHER	0	Jan 18, 2022	clinicaltrials